Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
28.91
-0.01 (-0.03%)
Nov 5, 2026, 1:00 PM EST - Market open
Lycia Therapeutics Employees
Lycia Therapeutics had 31 employees as of June 30, 2026. The number of employees increased by 2 or 6.90% since the number was reported on December 31, 2025. That makes Lycia Therapeutics the 36,964th largest employer in the world and 5,144th in the United States.
Employees
31
Change
2
Growth
6.90%
Revenue / Employee
$143,065
Profits / Employee
-$968,774
Market Cap
1.67B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 31 | 2 | 6.90% |
| Dec 31, 2025 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| Immunocore Holdings | 524 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 305 |
| uniQure | 221 |
| Innoviva | 159 |
| Nanobiotix | 98 |
| Rapport Therapeutics | 84 |
LYCA News
- 9 days ago - Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 11 days ago - Forget Anthropic: Biotech Is Quietly Dominating the IPO Sphere - Barrons
- 13 days ago - Lycia Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 16 days ago - Lycia Therapeutics Registration statement: Registration filing - Filings
- 16 days ago - Drug developer Lycia Therapeutics targets $938 million valuation in US IPO - Reuters
- 4 weeks ago - Lycia Therapeutics files for a $100 million IPO, targeting food allergies and autoimmune diseases - Renaissance Capital
- 4 weeks ago - Lycia Therapeutics IPO Registration Document (S-1) - SEC
- 4 weeks ago - Lycia Therapeutics Registration statement: Registration filing - Filings